Items where authors include "Laurent-Puig, P"

Article

Argiles, G, Tabernero, J, Labianca, R et al. (10 more authors) (2020) Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. Annals of Oncology, 31 (10). pp. 1291-1305. ISSN 0923-7534

Zhang, H, Ahearn, TU, Lecarpentier, J et al. (269 more authors) (2020) Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nature Genetics, 52 (6). pp. 572-581. ISSN 1061-4036

Lutz, MP, Zalcberg, JR, Ducreux, M et al. (21 more authors) (2019) The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma. European Journal of Cancer, 112. pp. 1-8. ISSN 0959-8049

Rosmarin, D, Palles, C, Church, D et al. (41 more authors) (2014) Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. Journal of Clinical Oncology, 32 (10). 1031 - 1039. ISSN 0732-183X

Garcia-Closas, M, Couch, FJ, Lindstrom, S et al. (271 more authors) (2013) Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature Genetics, 45 (4). pp. 392-398. ISSN 1061-4036

Bojesen, SE, Pooley, KA, Johnatty, SE et al. (442 more authors) (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics, 45 (4). pp. 371-384. ISSN 1061-4036

Proceedings Paper

Laurent-Puig, P, Paget-Bailly, S, Vernerey, D et al. (12 more authors) (2015) Evaluation of miR 31 3p as a biomarker of prognosis and panitumumab benefit in RAS-wt advanced colorectal cancer (aCRC): Analysis of patients (pts) from the PICCOLO trial. In: Journal of Clinical Oncology. 2015 ASCO Annual Meeting, 29 May - 02 Jun 2015, Chicago, IL. American Society of Clinical Oncology .